STOCK TITAN

Verano Announces Third Quarter 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Verano Holdings reported Q3 2024 financial results with revenues of $217 million, down 2.6% from the previous quarter and 9.7% year-over-year. The company posted a gross profit of $109 million (50% of revenue) and a net loss of $43 million. The decline in revenue was primarily attributed to decreased Florida retail sales due to temporary cultivation output shifts and expected declines in Illinois and New Jersey retail operations. Operating expenses increased due to higher headcount from new store openings. The company expanded its retail footprint with new MÜV and Zen Leaf locations, now operating 152 dispensaries across 14 states.

Verano Holdings ha riportato i risultati finanziari del terzo trimestre del 2024 con ricavi pari a 217 milioni di dollari, in calo del 2,6% rispetto al trimestre precedente e del 9,7% rispetto all’anno precedente. L'azienda ha registrato un utile lordo di 109 milioni di dollari (50% dei ricavi) e una perdita netta di 43 milioni di dollari. Il calo dei ricavi è stato principalmente attribuito alla diminuzione delle vendite al dettaglio in Florida a causa di spostamenti temporanei nella produzione agricola e agli attesi cali nelle operazioni al dettaglio in Illinois e New Jersey. Le spese operative sono aumentate a causa dell’aumento del personale per le aperture di nuovi negozi. L'azienda ha ampliato la sua presenza al dettaglio con nuove location MÜV e Zen Leaf, ora operando 152 dispensari in 14 stati.

Verano Holdings reportó resultados financieros del tercer trimestre de 2024 con ingresos de 217 millones de dólares, una disminución del 2.6% con respecto al trimestre anterior y del 9.7% interanual. La compañía reportó una ganancia bruta de 109 millones de dólares (50% de los ingresos) y una pérdida neta de 43 millones. La disminución en los ingresos se atribuyó principalmente a la reducción de las ventas minoristas en Florida debido a cambios temporales en la producción agrícola y se esperaban descensos en las operaciones minoristas en Illinois y Nueva Jersey. Los gastos operativos aumentaron debido al incremento del personal por las nuevas aperturas de tiendas. La compañía expandió su presencia minorista con nuevas ubicaciones de MÜV y Zen Leaf, operando ahora 152 dispensarios en 14 estados.

Verano Holdings는 2024년 3분기 재무 결과를 보고했으며, 수입은 2억 1,700만 달러로 전 분기 대비 2.6% 감소하고 전년 대비 9.7% 감소했습니다. 회사는 총 이익이 1억 900만 달러(수익의 50%) 및 순손실이 4,300만 달러 임을 보고했습니다. 수익 감소는 플로리다의 소매 매출 감소, 임시 재배 생산 변화 및 일리노이와 뉴저지의 소매 운영 감소가 주로 원인으로 분석됩니다. 운영 비용은 신규 매장 개설로 인한 인력 증가로 인해 증가했습니다. 이 회사는 새로운 MÜV 및 Zen Leaf 매장을 오픈하면서 소매 점포를 확대하였으며, 현재 14개 주에서 152개의 약국을 운영하고 있습니다.

Verano Holdings a rapporté les résultats financiers du troisième trimestre de 2024 avec des revenus de 217 millions de dollars, en baisse de 2,6% par rapport au trimestre précédent et de 9,7% d'une année sur l'autre. L'entreprise a affiché un bénéfice brut de 109 millions de dollars (50% des revenus) et une perte nette de 43 millions de dollars. La baisse des revenus a été principalement attribuée à la diminution des ventes au détail en Floride en raison de changements temporaires dans la production agricole et à des baisses attendues des opérations de vente au détail dans l'Illinois et le New Jersey. Les dépenses d'exploitation ont augmenté en raison d'une hausse de l'effectif due à de nouvelles ouvertures de magasins. L'entreprise a élargi son empreinte de vente au détail avec de nouveaux emplacements MÜV et Zen Leaf, maintenant 152 dispensaires dans 14 États.

Verano Holdings berichtete über die finanziellen Ergebnisse des dritten Quartals 2024 mit Einnahmen von 217 Millionen Dollar, was einem Rückgang von 2,6% im Vergleich zum vorherigen Quartal und 9,7% im Vergleich zum Vorjahr entspricht. Das Unternehmen meldete einen Bruttogewinn von 109 Millionen Dollar (50% der Einnahmen) und einen Nettverlust von 43 Millionen Dollar. Der Rückgang der Einnahmen wurde hauptsächlich auf verringerte Einzelhandelsverkäufe in Florida aufgrund temporärer Verschiebungen der Anbauausgaben und erwarteter Rückgänge in den Einzelhandelsbetrieben in Illinois und New Jersey zurückgeführt. Die Betriebskosten stiegen aufgrund eines höheren Personalbedarfs durch die Eröffnung neuer Geschäfte. Das Unternehmen erweiterte seine Einzelhandelspräsenz mit neuen MÜV- und Zen Leaf-Standorten und betreibt nun 152 Apotheken in 14 Bundesstaaten.

Positive
  • Maintained strong gross profit margin of 50%
  • Generated $30 million in operating cash flow
  • Expanded retail presence to 152 dispensaries across 14 states
  • Successfully launched adult-use sales in Ohio and Connecticut markets
Negative
  • Revenue declined 9.7% year-over-year to $217 million
  • Net loss increased to $43 million from $18 million in Q3 2023
  • SG&A expenses increased to 43% of revenue from 36% year-over-year
  • Adjusted EBITDA decreased to $64 million from $89 million year-over-year
  • Working capital deficit of $114 million

CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30, 2024, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Third Quarter 2024 Financial Highlights

  For the Three Months Ended, 
($ in thousands) September 30, 2024  June 30, 2024  September 30, 2023 
Revenues, net of Discounts $216,683  $222,390  $240,088 
Gross Profit  109,097   114,340   133,220 
Income from Operations  16,770   27,266   40,288 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries  (42,567)  (21,764)  (17,842)
Adjusted EBITDA1  64,458   70,599   89,349 


Third Quarter 2024 Financial Highlights

  • Revenues, net of discounts, of $217 million, a decrease of 2.6% versus the prior quarter.
  • Gross profit of $109 million or 50% of revenue.
  • SG&A expense of $92 million or 43% of revenue.
  • Net loss of $(43) million or (20)% of revenue.
  • Adjusted EBITDA1 of $64 million or 30% of revenue.
  • Net cash provided by operating activities of $30 million.
  • Capital expenditures of $57 million.

Management Commentary

“During this election season, for the first time in history, cannabis took center stage as a key bipartisan issue for both U.S. presidential candidates and millions of voters across the nation,” said George Archos, Verano founder, Chairman and Chief Executive Officer. “Despite the Amendment 3 outcome, it was encouraging to see the measure supported by a majority of Floridians with 56% voting in favor, and we remain optimistic on our growth prospects in the state and our ability to succeed in the current environment."

Archos concluded: "With rescheduling proceedings set to commence in December, and additional dispensary openings planned across multiple markets, we are prepared to leverage potential catalysts in the months and years ahead at the state and federal levels. Given his prior supportive comments, we look forward to working with President-elect Trump and his administration to advance the rescheduling process and much-needed reforms, including tax relief and SAFER banking.”

Third Quarter 2024 Financial Overview

Revenue for the third quarter 2024 was $217 million, down from $240 million for the third quarter 2023, and down from $222 million for the second quarter 2024. The decrease in revenue for the third quarter 2024 compared to the third quarter 2023 was driven primarily by declines in Florida retail due to a temporary shift in cultivation output, in addition to expected declines in Illinois and New Jersey retail as dispensaries continue to open across the state.

Gross profit for the third quarter 2024 was $109 million or 50% of revenue, down from $133 million or 55% of revenue for the third quarter 2023, and down from $114 million or 51% of revenue for the second quarter 2024. The decrease in gross profit for the third quarter 2024 compared to the third quarter 2023 was primarily due to declines in revenue.

SG&A expense for the third quarter 2024 was $92 million or 43% of revenue, up from $86 million or 36% of revenue for the third quarter 2023, and up from $87 million or 39% of revenue for the second quarter 2024. The increase in SG&A expense for the third quarter 2024 compared to the third quarter 2023 was driven primarily by an increase in salaries and benefits, due to increased headcounts related to new store openings.

Net loss for the third quarter 2024 was $(43) million, or (20)% of revenue, versus $(18) million, or (7)% of revenue in the third quarter 2023. The increase in net loss for the third quarter 2024 compared to the third quarter 2023 was largely driven by declines in income from operations.

Adjusted EBITDA1 for the third quarter 2024 was $64 million or 30% of revenue.

Net cash provided by operating activities year to date was $69 million, down from $77 million for the prior year period.

Capital expenditures year to date were $85 million, up from $27 million for the prior year period.

2024 Guidance

  • The Company expects organic trends similar to those seen in the third quarter 2024 to continue into the fourth quarter 2024.

Third Quarter 2024 Operational Highlights

  • Expanded the Company's retail footprint by opening the following new dispensaries:
    • MÜV locations in Melbourne and Okeechobee, elevating the Company's Florida retail operations to 79 dispensaries statewide;
    • Zen Leaf Fairless Hills in Pennsylvania, which relocated to a prime new Philadelphia area location;
    • and Zen Leaf Arcadia in Arizona, featuring an array of new dispensary features and customer conveniences, which relocated to an enhanced Phoenix location.
  • Introduced Cabbage Club, the first nationwide proprietary multi-state cannabis membership club, in Connecticut, Maryland and Michigan on July 1, following its April debut in the Illinois and New Jersey markets.
  • Welcomed adult use customers at the Company's five Ohio Zen Leaf dispensaries on August 6th.
  • Completed acquisition of Arizona and Virginia subsidiaries of The Cannabist Company Holdings Inc., confirming the Company's position as exclusive cannabis operator for HSA 5 in Eastern Virginia, and strengthening its Arizona footprint.
  • In late September, launched "Save the Bits" fundraising campaign featuring BITS edibles and coalition of hundreds of dispensaries across eight states benefiting the Lynn Sage Breast Cancer Foundation.

Subsequent Operational Highlights

  • Issued Company donation, and launched "Round Up for Relief" fundraising campaign across Florida MÜV dispensaries to support Red Cross hurricane relief efforts.
  • Commenced adult use sales at Zen Leaf Waterbury, completing the conversion of all five existing Connecticut Zen Leaf dispensaries from medical to hybrid sales.
  • Current operations span 14 states, comprised of 152 dispensaries and 15 production facilities with more than 1.1 million square feet of cultivation capacity.

Balance Sheet and Liquidity

As of September 30, 2024, the Company’s current assets were $322 million, including cash and cash equivalents of $65 million. The Company had a working capital deficit of $(114) million and total debt, net of issuance costs, of $420 million.

The Company’s total Class A subordinate voting shares outstanding was 356,925,414 as of September 30, 2024.

Conference Call and Webcast

A conference call and webcast with analysts and investors is scheduled for November 7, 2024 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.

_________________________

1Adjusted EBITDA and adjusted EBITDA as a percentage of revenue (“adjusted EBITDA margin”) are non-U.S. GAAP financial measures. Each is derived from EBITDA, another non-U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The most directly comparable U.S. GAAP financial measure to adjusted EBITDA is net income (loss) and the most directly comparable measure to adjusted EBITDA margin is net income (loss) as a percentage of revenue (“net income (loss) margin”). The reconciliation of (i) adjusted EBITDA to U.S. GAAP net income (loss) and (ii) adjusted EBITDA margin to net income (loss) margin is set forth below in the tables included in this news release.

Non-U.S. GAAP Financial Measures

Verano uses non-U.S. GAAP financial information to evaluate the performance of the Company. The terms “EBIT,” “EBITDA,” “adjusted EBITDA margin,” and "Operating Cash Flow" do not have any standardized meaning prescribed within U.S. GAAP and therefore may not be comparable to similar measures presented by other companies. Accordingly, this non-U.S. GAAP financial information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with U.S. GAAP.

The Company calculates EBIT as net income (loss) before interest expense and income tax expense; EBITDA as net income (loss) before interest expense, income tax expense, depreciation, and amortization; and adjusted EBITDA as net income (loss) plus net interest expense, income tax expense, depreciation and amortization and also excludes certain one-time extraordinary items. The calculations of the non-U.S. GAAP financial measures used in this news release and the reconciliations to the most comparable U.S. GAAP financial numbers are included in the tables below.

Operating Cash Flow is a non-U.S. GAAP financial measure. It is derived from U.S. GAAP net income (loss) which is also its most directly comparable U.S. GAAP financial measure. The reconciliation of operating cash flow to U.S. GAAP net income (loss) is set forth below in the tables included in this news release.

Management believes that this non-U.S. GAAP financial information is useful as a supplement to comparable U.S. GAAP financial information because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP information to supplement their GAAP results. Management reviews these non-U.S. GAAP financial measures on a regular basis and uses them, together with financial measures included in the Company’s financial statements, to evaluate and manage the performance of the Company’s operations. These measures should be evaluated only in conjunction with the comparable U.S. GAAP financial numbers reported by the Company.

About Verano

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners, including Cabbage Club, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, (the) Essence, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 14 U.S. states, comprised of 15 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.

Contacts:
Investors
Verano
Julianna Paterra, CFA
VP, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
VP, Communications
steve.mazeika@verano.com
312-348-4430

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2023 and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

Financial Information Tables

The following tables include select financial results and the reconciliations of the non-U.S. GAAP financial measures to the respective most directly comparable U.S. GAAP financial measures for the presented periods.

VERANO HOLDINGS CORP.
Highlights from Unaudited Interim Condensed Consolidated Statements of Operations (Unaudited)
($ in Thousands)

  For the Three Months Ended, 
  September 30, 2024  June 30, 2024  September 30, 2023 
Revenues, net of Discounts $216,683  $222,390  $240,088 
Cost of Goods Sold, net  107,586   108,050   106,868 
Gross Profit  109,097   114,340   133,220 
Gross Profit %  50%  51%  55%
Operating Expenses            
Selling, General and Administrative  92,327   87,074   86,316 
Loss on Impairment - Investment in Associates        6,571 
Total Operating Expenses  92,327   87,074   92,887 
Loss from Investments in Associates        (45)
Income from Operations  16,770   27,266   40,288 
Other Income (Expense), net:            
Loss on Disposal of Property, Plant and Equipment  (604)     (234)
Loss on Debt Extinguishment     (3,068)   
Interest Expense, net  (12,771)  (14,237)  (15,166)
Other Income (Expense), net  (484)  (1,195)  2,145 
Total Other Income (Expense), Net  (13,859)  (18,500)  (13,255)
Income Before Provision for Income Taxes  2,911   8,766   27,033 
Provision for Income Taxes  (45,478)  (30,530)  (44,797)
Net Income Attributable to Non-Controlling Interest        78 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries  (42,567)  (21,764)  (17,842)


VERANO HOLDINGS CORP.
Highlights from Condensed Consolidated Balance Sheets
($ in Thousands) 

  September 30, 2024  December 31, 2023 
   (Unaudited)     
Cash and Cash Equivalents $64,981  $174,760 
Other Current Assets  256,740   219,436 
Property, Plant and Equipment, net  584,598   501,304 
Intangible Assets, net  1,047,519   1,086,146 
Goodwill  252,182   231,291 
Other Long-Term Assets  108,659   105,808 
Total Assets $2,314,679  $2,318,745 
         
Total Current Liabilities  435,375   412,188 
Total Long-Term Liabilities  661,586   666,477 
Shareholders' Equity  1,217,944   1,240,080 
Non-Controlling Interest  (226)   
Total Liabilities and Shareholders' Equity $2,314,679  $2,318,745 


VERANO HOLDINGS CORP.
Segmented Revenues, net of Discounts, By State (Unaudited)

  For the Three Months Ended,  For the Nine Months Ended, 
Retail Revenues, net of Discounts September 30, 2024  September 30, 2024 
($ in thousands)        
Florida $45,301  $144,801 
Illinois  23,926   77,602 
New Jersey  19,991   63,683 
Arizona  14,653   44,098 
Pennsylvania  11,266   35,043 
Maryland  11,315   32,632 
Connecticut  9,845   30,054 
Nevada  6,828   21,181 
Ohio  8,585   19,518 
Massachusetts  2,909   8,800 
West Virginia  1,899   5,465 
Virginia  4,720   4,720 
Other  3,166   10,078 
Total Retail Revenues, net of Discounts $164,404  $497,675 


  For the Three Months Ended,  For the Nine Months Ended, 
  September 30, 2024  September 30, 2024 
Wholesale Revenues, net of Discounts Gross  Net1  Gross  Net1 
($ in thousands)            
New Jersey $21,570  $13,970  $69,446  $49,174 
Illinois  21,003   13,373   61,253   38,127 
Connecticut  14,088   9,532   41,814   28,636 
Maryland  8,859   4,974   25,787   15,156 
Pennsylvania  6,387   2,544   19,158   9,571 
Arizona  6,286   2,255   19,424   7,182 
Nevada  2,439   939   8,912   3,015 
Ohio  3,866   1,904   8,816   4,405 
Massachusetts  1,885   1,085   5,951   3,488 
West Virginia  2,394   1,317   6,595   3,564 
Virginia $1,673  $386  $1,673  $386 
Total Wholesale Revenues, net of Discounts $90,450  $52,279  $268,829  $162,704 

1Net of intercompany eliminations

VERANO HOLDINGS CORP.
Reconciliation of Net Loss to Operating Cash Flow (Non-U.S. GAAP)

  For the Nine Months Ended, 
  September 30, 2024  September 30, 2023 
($ in thousands) (Unaudited)  (Unaudited) 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries $(69,153) $(40,140)
Depreciation and Amortization  108,150   105,559 
Other Non-cash Adjustments  34,683   24,995 
Operating Cash Flow $73,680  $90,414 


VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP)

  For the Three Months Ended, 
  September 30, 2024  June 30, 2024  September 30, 2023 
($ in thousands) (Unaudited)  (Unaudited)  (Unaudited) 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries $(42,567) $(21,764) $(17,842)
Interest Expense, net  12,771   14,237   15,166 
Income Tax Expense  45,478   30,530   44,797 
Depreciation and Amortization - COGS  19,433   18,749   18,384 
Depreciation and Amortization - SG&A  17,432   16,984   16,882 
Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) $52,547  $58,736  $77,387 


VERANO HOLDINGS CORP.
Reconciliation of Net Loss to EBIT (Non-U.S. GAAP) and Adjusted EBITDA (Non-U.S. GAAP)

  For the Three Months Ended, 
  September 30, 2024  June 30, 2024  September 30, 2023 
($ in thousands) (Unaudited)  (Unaudited)  (Unaudited) 
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries  (42,567)  (21,764)  (17,842)
Interest Expense, Net  12,771   14,237   15,166 
Income Tax Expense  45,478   30,530   44,797 
Earnings Before Interest, Taxes (EBIT) $15,682  $23,003  $42,121 
             
COGS Add-backs:            
Depreciation and Amortization - COGS  19,433   18,749   18,384 
Acquisition, Transaction and Other Non-operating Costs  3,280       
Employee Stock Compensation  733   680   625 
             
SG&A Add-backs:            
Depreciation and Amortization - SG&A  17,432   16,984   16,882 
Acquisition, Transaction and Other Non-operating Costs  2,138   2,570   617 
Employee Stock Compensation  4,057   3,636   4,062 
             
Acquisition Adjustments and Other Income (Expense), net  1,703   4,977   6,658 
             
Adjusted EBITDA $64,458  $70,599  $89,349 
             
Net Loss Margin  (20)%  (10)%  (7)%
Adjusted EBITDA Margin  30%  32%  37%



FAQ

What was Verano's (VRNOF) revenue in Q3 2024?

Verano reported revenue of $217 million in Q3 2024, representing a 2.6% decrease from Q2 2024 and a 9.7% decrease from Q3 2023.

How many dispensaries does Verano (VRNOF) operate as of Q3 2024?

Verano operates 152 dispensaries across 14 states, with 15 production facilities totaling over 1.1 million square feet of cultivation capacity.

What caused Verano's (VRNOF) revenue decline in Q3 2024?

The revenue decline was primarily due to decreased Florida retail sales from temporary cultivation output shifts and expected declines in Illinois and New Jersey retail operations.

What was Verano's (VRNOF) net loss in Q3 2024?

Verano reported a net loss of $43 million in Q3 2024, compared to a net loss of $18 million in Q3 2023.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

610.70M
302.30M
15.59%
10.6%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago